Literature DB >> 15384963

Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea.

E S Kim1, S-M Han, Y I Kim, K-H Song, M-S Kim, W B Kim, J-Y Park, K-U Lee.   

Abstract

AIMS: To determine the prevalence of metabolic syndrome according to the criteria of the Adult Treatment Panel III (ATP III) and the World Health Organization (WHO).
METHODS: Data were collected from 1108 subjects over 40 years of age in the Chongup district, a rural area of South Korea. We evaluated the prevalence and clinical characteristics of metabolic syndrome according to the two criteria.
RESULTS: According to the ATP III criteria, the prevalence of central obesity was 0.2% in men and 27.3% in women, which is much lower than the prevalence of central obesity in Americans. However, the prevalence of metabolic syndrome was similar to the prevalence in Americans. Of the Korean subjects over 40 years of age, 29.4% and 39.2% had metabolic syndrome according to the ATP III and WHO criteria, respectively. Metabolic syndrome according to the ATP III criteria was associated with insulin resistance, but not with microalbuminuria.
CONCLUSIONS: Metabolic syndrome has a high prevalence in South Koreans despite the low prevalence of obesity and/or central obesity.

Entities:  

Mesh:

Year:  2004        PMID: 15384963     DOI: 10.1111/j.1464-5491.2004.01398.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

1.  Association Between Elevated Liver Enzymes and Metabolic Syndrome Among Thai Adults.

Authors:  Sajithya Perera; Vitool Lohsoonthorn; Wiroj Jiamjarasrangsi; Somrat Lertmaharit; Michelle A Williams
Journal:  Diabetes Metab Syndr       Date:  2008-09

2.  Variable association between components of the metabolic syndrome and electrocardiographic abnormalities in Korean adults.

Authors:  Hong-Kyu Kim; Chul-Hee Kim; Kwan-Ho Ko; Seong-Wook Park; Joong-Yeol Park; Ki-Up Lee
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

3.  Diabetes, insulin resistance and atherosclerosis surrogates in patients with coronary atherosclerosis.

Authors:  Hyun-Woong Park; Taek Geun Kown; Ki-Young Kim; Jang-Ho Bae
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

4.  Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults.

Authors:  Sihoon Lee; Sunghee Choi; Hae Jin Kim; Yoon-Sok Chung; Kwan Woo Lee; Hyun Chul Lee; Kap Bum Huh; Dae Jung Kim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

5.  Causes of different estimates of the prevalence of metabolic syndrome in Korea.

Authors:  Hyeon Chang Kim; Dae Jung Kim
Journal:  Korean J Intern Med       Date:  2011-11-28       Impact factor: 2.884

6.  Metabolic syndrome is associated with change in subclinical arterial stiffness: a community-based Taichung community health study.

Authors:  Chia-Ing Li; Sharon Lr Kardia; Chiu-Shong Liu; Wen-Yuan Lin; Chih-Hsueh Lin; Yi-Dar Lee; Fung-Chang Sung; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  BMC Public Health       Date:  2011-10-17       Impact factor: 3.295

7.  Urban-Rural Differences in Cardiovascular Disease Risk Factors: A Cross-Sectional Study of Schoolchildren in Wuhan, China.

Authors:  Kayne McCarthy; Long-biao Cai; Fang-rong Xu; Pei-gang Wang; Hong-liang Xue; Yong-ling Ye; Shang-zhi Xiong; Zhao-min Liu; Qi-qiang He
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

8.  Low levels of physical activity are associated with increased metabolic syndrome risk factors in korean adults.

Authors:  Dong Hoon Lee; Yoon Myung Kim; Yoonsuk Jekal; Sukyung Park; Kyong-Chol Kim; Masayo Naruse; Sun Hyun Kim; Sang-Hwan Kim; Ji-Hye Park; Mi Kyung Lee; Sang Hui Chu; Justin Y Jeon
Journal:  Diabetes Metab J       Date:  2013-04-16       Impact factor: 5.376

Review 9.  Clinical characteristics of metabolic syndrome in Korea, and its comparison with other Asian countries.

Authors:  A Ram Hong; Soo Lim
Journal:  J Diabetes Investig       Date:  2015-01-07       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.